Reviv3 Procare Company (RVIV) Q1 2026 Earnings Report

Reviv3 Procare Company reported QQ1 2026 with a disclosed gross profit of 4,634,934 USD and an operating income of 990,221 USD, alongside depreciation and amortization of 62,087 USD. EBITDA was reported as 62,087 USD, which appears to align with the depreciation charge rather than the typical EBITDA definition; management commentary on this quarter’s revenue base is not provided in the data, leaving top-line visibility limited. The company carries a solid liquidity position, with cash and cash equivalents of 4,086,624 USD and a net cash position of approximately -3,522,761 USD (net debt), reflecting very low leverage (debt ratio around 3.7% and debt to equity near 5.5%). The current ratio stands at 2.59 and the quick ratio at 1.73, signaling a comfortable short-term liquidity profile even without disclosed revenue figures for QQ1 2026.